UFP Technologies will present at the Piper Sandler Healthcare Conference in New York on December 3, 2025.
Quiver AI Summary
UFP Technologies, Inc. has announced that its leadership, including Chairman and CEO R. Jeffrey Bailly, President Mitchell C. Rock, and CFO Ron Lataille, will present at the Piper Sandler 37th Annual Healthcare Conference in New York City from December 1-4, 2025, with their presentation set for 8:10 AM on December 3rd. The presentation will focus on UFP's role as a contract development and manufacturing organization specializing in single-use and single-patient medical devices, which are essential to the medical device supply chain and serve various applications such as minimally invasive surgery and wound care. A live audio webcast of the presentation will be available.
Potential Positives
- UFP Technologies is actively participating in a prominent industry event, the Piper Sandler Healthcare Conference, which enhances its visibility in the medical device sector.
- The company’s presentation schedule indicates a proactive approach to engage with investors and stakeholders, fostering relationships and potentially attracting new partnerships.
- Being recognized as a vital link in the medical device supply chain positions UFP Technologies favorably in the market, highlighting its importance to major medical device manufacturers.
- The focus on single-use and single-patient medical devices aligns with current trends in healthcare, emphasizing innovation in areas like minimally invasive surgery and infection prevention.
Potential Negatives
- None
FAQ
What is UFP Technologies, Inc.?
UFP Technologies, Inc. is a contract development and manufacturing organization specializing in single-use and single-patient medical devices.
When will UFP Technologies present at the Piper Sandler Healthcare Conference?
UFP Technologies will present on Wednesday, December 3rd, at 8:10 AM during the Piper Sandler 37th Annual Healthcare Conference.
Who are the key executives participating in the conference?
The key executives participating are R. Jeffrey Bailly, Mitchell C. Rock, and Ron Lataille.
How can I access the live audio webcast of UFP's presentation?
A live audio webcast of UFP's presentation will be available through the company's official website.
What types of medical devices does UFP Technologies focus on?
UFP Technologies focuses on single-use and single-patient devices used in various medical applications, including minimally invasive surgery and infection prevention.
Disclaimer: This is an AI-generated summary of a press release distributed by GlobeNewswire. The model used to summarize this release may make mistakes. See the full release here.
$UFPT Insider Trading Activity
$UFPT insiders have traded $UFPT stock on the open market 12 times in the past 6 months. Of those trades, 0 have been purchases and 12 have been sales.
Here’s a breakdown of recent trading of $UFPT stock by insiders over the last 6 months:
- DANIEL C CROTEAU has made 0 purchases and 2 sales selling 2,873 shares for an estimated $591,883.
- CHRISTOPHER P. LITTERIO (Senior Vice President) has made 0 purchases and 10 sales selling 1,829 shares for an estimated $415,549.
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
$UFPT Hedge Fund Activity
We have seen 133 institutional investors add shares of $UFPT stock to their portfolio, and 169 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- INVESCO LTD. removed 149,367 shares (-84.9%) from their portfolio in Q3 2025, for an estimated $29,813,653
- ROCKEFELLER CAPITAL MANAGEMENT L.P. added 86,128 shares (+inf%) to their portfolio in Q3 2025, for an estimated $17,191,148
- ALLSPRING GLOBAL INVESTMENTS HOLDINGS, LLC added 85,457 shares (+469.4%) to their portfolio in Q3 2025, for an estimated $17,057,217
- MOUNTAIN PACIFIC INVESTMENT ADVISERS LLC removed 81,516 shares (-82.4%) from their portfolio in Q3 2025, for an estimated $16,270,593
- GENEVA CAPITAL MANAGEMENT LLC added 74,461 shares (+88.6%) to their portfolio in Q3 2025, for an estimated $14,862,415
- AMERICAN CENTURY COMPANIES INC removed 71,515 shares (-22.0%) from their portfolio in Q3 2025, for an estimated $14,274,394
- MILLENNIUM MANAGEMENT LLC removed 64,920 shares (-95.9%) from their portfolio in Q3 2025, for an estimated $12,958,032
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
$UFPT Analyst Ratings
Wall Street analysts have issued reports on $UFPT in the last several months. We have seen 1 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- Lake Street issued a "Buy" rating on 08/06/2025
To track analyst ratings and price targets for $UFPT, check out Quiver Quantitative's $UFPT forecast page.
Full Release
NEWBURYPORT, Mass., Nov. 25, 2025 (GLOBE NEWSWIRE) -- UFP Technologies, Inc . ( Nasdaq: UFPT ) a contract development and manufacturing organization that specializes in single-use and single-patient medical devices, today announced that Chairman and Chief Executive Officer R. Jeffrey Bailly, President Mitchell C. Rock, and Chief Financial Officer Ron Lataille will participate in the upcoming Piper Sandler 37 th Annual Healthcare Conference to be held in New York City December 1-4, 2025. UFP’s presentation is scheduled to begin at 8:10 AM on Wednesday, December 3 rd . A live audio webcast of UFP’s presentation will be available here .
About UFP Technologies, Inc.
UFP Technologies is a contract development and manufacturing organization that specializes in single-use and single-patient medical devices. UFP is a vital link in the medical device supply chain and a valued outsourcing partner to many of the world's top medical device manufacturers. The Company’s single-use and single-patient devices and components are used in a wide range of medical devices and packaging for minimally invasive surgery, infection prevention, wound care, wearables, orthopedic soft goods, and orthopedic implants.
Contacts:
Ron Lataille, CFO, UFP Technologies, Inc., tel. 978-234-0926
[email protected]
Jeff Elliott, Three Part Advisors, LLC, tel. 214-966-9014
[email protected]
